14,544 Shares in Stevanato Group S.p.A. (NYSE:STVN) Purchased by Fox Run Management L.L.C.

Fox Run Management L.L.C. purchased a new position in shares of Stevanato Group S.p.A. (NYSE:STVN) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 14,544 shares of the company’s stock, valued at approximately $317,000.

Several other large investors have also made changes to their positions in STVN. Van Berkom & Associates Inc. bought a new stake in shares of Stevanato Group during the 4th quarter worth $39,000. PNC Financial Services Group Inc. increased its position in Stevanato Group by 1,457.6% during the 4th quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company’s stock worth $123,000 after purchasing an additional 5,291 shares in the last quarter. US Bancorp DE increased its holdings in shares of Stevanato Group by 17.9% during the fourth quarter. US Bancorp DE now owns 8,527 shares of the company’s stock worth $186,000 after buying an additional 1,295 shares in the last quarter. Marco Investment Management LLC bought a new stake in Stevanato Group during the 4th quarter worth $203,000. Finally, Hardy Reed LLC grew its holdings in shares of Stevanato Group by 8.2% during the third quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock worth $222,000 after purchasing an additional 840 shares during the last quarter.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. UBS Group cut their price target on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a report on Friday, March 7th. Bank of America upped their price objective on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, December 13th. William Blair restated an “outperform” rating on shares of Stevanato Group in a report on Friday, March 7th. Morgan Stanley reissued an “equal weight” rating and issued a $23.00 price objective (down from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. Finally, Wolfe Research initiated coverage on Stevanato Group in a research note on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, Stevanato Group presently has a consensus rating of “Moderate Buy” and a consensus target price of €25.70 ($27.63).

Stevanato Group Price Performance

Shares of NYSE:STVN opened at €21.00 ($22.58) on Thursday. Stevanato Group S.p.A. has a 1-year low of €16.56 ($17.81) and a 1-year high of €33.49 ($36.01). The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. The stock has a market cap of $6.36 billion, a PE ratio of 44.68, a price-to-earnings-growth ratio of 7.18 and a beta of 0.60. The stock’s fifty day simple moving average is €21.01 and its two-hundred day simple moving average is €20.59.

Stevanato Group (NYSE:STVN) last announced its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share for the quarter, hitting analysts’ consensus estimates of €0.20 ($0.22). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm had revenue of €352.68 million for the quarter, compared to the consensus estimate of €346.26 million. As a group, analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.